Home / drugs / Glyxambi (empagliflozin and linagliptin)

Glyxambi (empagliflozin and linagliptin)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

July 2016

WARNINGS AND PRECAUTIONS

Ketoacidosis (addition of the following sentence in first paragraph)

Fatal cases listed

About Ajay C

Check Also

Drug rehab in the US – getting help when you need it most

Across the US, there are men and women who suffer the consequences of drug abuse. …